Inventor
SADELAIN MICHEL
US34 patents
⚠️ This page may combine multiple inventors who share the name “SADELAIN MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEMORIAL SLOAN KETTERING CANCER CENTER
25 patentsUS10117897B2Nov 6, 2018
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
MEMORIAL SLOAN KETTERING CANCER CENTER13 citations92
US10370452B2Aug 6, 2019
Effective generation of tumor-targeted T cells derived from pluripotent stem cells
MEMORIAL SLOAN KETTERING CANCER CENTER21 citations88
US11242375B2Feb 8, 2022
Immune cell compositions and methods of use
MEMORIAL SLOAN KETTERING CANCER CENTER5 citations83
US10654928B2May 19, 2020
Compositions and methods for immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER12 citations83
US10730941B2Aug 4, 2020
Antigen-binding proteins targeting CD56 and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER10 citations82
US11267901B2Mar 8, 2022
Compositions and methods for immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER12 citations81
US12263220B2Apr 1, 2025
Compositions and methods for immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations72
US11702472B2Jul 18, 2023
Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors
MEMORIAL SLOAN KETTERING CANCER CENTER2 citations72
US10633441B2Apr 28, 2020
Mesothelin-targeted chimeric antigen receptors and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER2 citations72
US10538588B2Jan 21, 2020
Mesothelin-targeted chimeric antigen receptors and methods of making them
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations72
US11717579B2Aug 8, 2023
Globin gene therapy for treating hemoglobinopathies
MEMORIAL SLOAN KETTERING CANCER CENTER3 citations68
US11932690B2Mar 19, 2024
Enhanced chimeric antigen receptors and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER4 citations66
US11229669B2Jan 25, 2022
Cells comprising non-HLA restricted T cell receptors
MEMORIAL SLOAN KETTERING CANCER CENTER3 citations66
US10350243B2Jul 16, 2019
Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursors
MEMORIAL SLOAN KETTERING CANCER CENTER3 citations65
US11753654B2Sep 12, 2023
Globin gene therapy for treating hemoglobinopathies
MEMORIAL SLOAN KETTERING CANCER CENTER2 citations64
US11077140B2Aug 3, 2021
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations62
US12139524B2Nov 12, 2024
Immune cell compositions and methods of use
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations61
US12275802B2Apr 15, 2025
Compositions and methods for immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations60
US12018077B2Jun 25, 2024
Methods of treatments using antigen-binding proteins targeting CD56
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations60
US11712469B2Aug 1, 2023
Compositions and methods for immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations60
US12345712B2Jul 1, 2025
Cancer antigen targets and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US12259390B2Mar 25, 2025
Cancer antigen targets and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US11193938B2Dec 7, 2021
Cancer antigen targets and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US12036244B2Jul 16, 2024
Cells comprising non-HLA restricted T cell receptors
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations56
US12331129B2Jun 17, 2025
Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations44
SLOAN KETTERING INST CANCER
5 patentsUS7446190B2Nov 4, 2008
Nucleic acids encoding chimeric T cell receptors
SLOAN KETTERING INST CANCER904 citations96
US6451995B1Sep 17, 2002
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
SLOAN KETTERING INST CANCER335 citations96
US6642043B1Nov 4, 2003
Double mutants of dihydrofolate reductase and methods of using same
SLOAN KETTERING INST CANCER29 citations88
US7541179B2Jun 2, 2009
Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
SLOAN KETTERING INST CANCER12 citations80
US6887467B1May 3, 2005
Double mutants of dihydrofolate reductase and methods of using same
SLOAN KETTERING INST CANCER0 citations48
SADELAIN MICHEL
3 patentsUS8389282B2Mar 5, 2013
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
SADELAIN MICHEL412 citations98
US9220728B2Dec 29, 2015
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
SADELAIN MICHEL42 citations96
US8058061B2Nov 15, 2011
Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
SADELAIN MICHEL4 citations58